Mechanisms of rotenone-induced neurotoxicity in PC 12 cells

Neural Regeneration Research

Volumn 3, Issue 12, 2008, Pages 1281-1285

  Han, Wei ^a   Sun, Lizhong ^a   Chen, Jiafeng ^b   Chang, Ming ^b   Huo, Hongyan ^a   Hu, Linsen ^b  

^a Jilin Brain Hospital   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Cytotoxic effect; PC 12 cells; Proteomics; Rotenone

Indexed keywords

CELL PROTEIN; HOE 33342; INITIATION FACTOR 4A; NEURON SPECIFIC ENOLASE; ROTENONE; TRIOSEPHOSPHATE ISOMERASE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; SURVIVAL RATE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 69749114122     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Eriksen JL, Wszolek Z, Petrucelli L. Molecular pathogenesis of Parkinson disease. Arch Neurol 2005;62(3):353-7
2. Betarbet R, Sherer TB, MacKenzie G, et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3(12):1301-6
3. Alam M, Schmidt WJ. Rotenone destroys dopaminergic neurons and induces Parkinsonian symptoms in rats. Behav Brain Res 2002;136(1):317-24
4. Höglinger GU, Féger J, Prigent A, et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 2003;84(3):491-502
5. Sherer TB, Kim JH, Betarbet R, et al. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003;179(1): 9-16
6. Fleming SM, Zhu C, Fernagut PO, et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 2004;187(2):418-29
7. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39(6):889-909
8. Rideout HJ, Larsen KE, Sulzer D, et al. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J Neurochem 2001;78(4):899-908
9. Meng XF, Zou XJ, Peng B, et al. Inhibition of ethanol-induced toxicity by tanshinone IIA in PC12 cells. Acta Pharmacol Sin 2006;27(6):659-64
10. Saito T, Kijima H, Kiuchi Y, et al. Beta-amyloid induces caspase-dependent early neurotoxic change in PC12 cells: correlation with H202 neurotoxicity. Neurosci Lett 2001; 305(1):61-4
11. Feng Z, Zhang JT. Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells. J Pineal Res 2004;37(4):257-66
12. Zhang L, Chang M, Li H, et al. Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI. Brain Res 2007; 1153:196-203
13. Swatton JE, Prabakaran S, Karp NA, et al. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol Psychiatry 2004;9(2):128-43
14. Zhang W, Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 2000;72(11):2482-9
15. Freeman WM, Hemby SE. Proteoxnics for protein expression profiling in neuroscience. Neurochem Res 2004;29(6):1065-81
16. Gharbi S, Gaffney P, Yang A, et al. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 2002;1(2):91-8
17. Hu Y, Wang G, Chen GY, et al. Proteome analysis of saccharomyces cerevisiae under metal stress by two-dimensional differential gel electrophoresis. Electrophoresis 2003;24(9):1458-70
18. Höglinger GU, Lannuzel A, Khondiker ME, et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 2005;95(4):930-9
19. Samantaray S, Knaryan VH, Guyton MK, et al. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 2007;146(2):741-55
20. Sultana R, Boyd-Kimball D, Cal J, et al. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 2007;11(2):153-64
21. Schonberger SJ, Edgar PF, Kydd R, et al. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 2001;1(12):1519-28
22. Yang GF, Wang LN, He SZ, et al. Proteomic study of Pick's disease. Zhonghua Shenjingke Zazhi 2006;39(2):96-100
23. Castegna A, Thongboonkerd V, Klein JB, et al. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003;85(6):1394-401
24. de la Cruz J, Kressler D, Linder P. Unwinding RNA in saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 1999;24(5):192-8
25. Song P, Zhang JN, Hu JR, et al. cDNA Cloning Expression and ATPase Assay of a Putative eIF-4A of Plasmodium cynomolgi. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao 2004;20(3):294-304